RxDoctor Payments Data

Catherine Blume

Family · Platteville, WINPI 1083602056

Payments from drug & device makers

$3,487in general payments, 2019–2025

Across 197 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$788
  • Boehringer Ingelheim$389
  • Lilly USA, LLC$293
  • Dexcom, Inc.$242
  • Pfizer$220
  • AstraZeneca$211
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$3,487100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,487 in reported general payments places this provider in the 90th percentile of 1,273 family providers in Wisconsin.

See all family providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide14$15,114
EliquisApixaban34$12,758
Incruse ElliptaUmeclidinium Bromide13$4,171
Memantine Hcl33$1,346
Warfarin Sodium59$1,031
Donepezil Hcl51$967
Albuterol Sulfate HfaAlbuterol Sulfate15$714
Losartan Potassium55$687
Venlafaxine Hcl ErVenlafaxine Hcl36$650
Gabapentin76$638
Levothyroxine Sodium69$591
Atorvastatin Calcium93$584
Pantoprazole Sodium33$507
Tamsulosin Hcl26$503
Memantine Hcl ErMemantine Hcl13$488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Olanzapine$293$15,23929 claims
PfizerEliquis$220$12,75834 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,273 family providers in Wisconsin.

Other family in Platteville

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →